Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
News|Articles|October 2, 2003
- Pharmaceutical Technology-10-02-2003
- Volume 27
- Issue 10
Outsourcing is Front Page News in 2003
Author(s)Jim Miller
Outsourcing is part of the public debate as politicians seek to explain the lag in job growth despite a recovering economy, and as the Bush administration presses its initiative to "competitively source" more agency activities.
Advertisement
Articles in this issue
almost 23 years ago
Designing a New Drug Packagealmost 23 years ago
GMP Update: Reducing Obstacles to Innovationalmost 23 years ago
Filling the Void: PAT in a Connected Manufacturing Environmentalmost 23 years ago
Process Analytical Technology Concepts and Principlesalmost 23 years ago
October 2003almost 23 years ago
October 2003almost 23 years ago
In the Spotlight - NovemberAdvertisement
Related to this article
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Shilpa Pharma Lifesciences Limited will launch a new small-molecule CDMO at CPHI Milan in October.
This article explains the 4 shifts enabling faster, lower-risk, commercially successful biologics technology transfer.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Can AI Agents Satisfy CGMP Documentation Requirements?
2
Spray Drying Capacity Signals Faster Paths for Poorly Soluble Drugs
3
PharmTech Weekly Roundup—September 18, 2026
4
Introducing the "PharmTech AI Pulse Check" Expert Video Series
5